| 【英語タイトル】Global Cell Dissociation Market Size study & Forecast, by Type (Tissue dissociation, Cell Detachment), by Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, Instruments & Accessories), by Tissue (Epithelial Tissue, Connective Tissue, Others), by End User (Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes, Others), and Regional Analysis, 2022-2029
|
 | ・商品コード：BZW23AP126
・発行会社（調査会社）：Bizwit Research & Consulting
・発行日：2023年3月20日
・ページ数：約200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野：バイオテクノロジー
|
◆販売価格オプション
（消費税別）
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
|
❖ レポートの概要 ❖
Bizwit Research社では、2021年におよそ282百万ドルであった世界の細胞解離市場規模が、2022年から2029年の間に14.7％以上成長すると予測しています。本調査レポートは、細胞解離の世界市場について総合的に調査・分析を行い、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、種類別（組織解離、細胞剥離）分析、製品種類別（酵素的解離製品、非酵素的解離製品、器具＆付属品）分析、組織別（上皮組織、結合組織、その他）分析、エンドユーザー別（バイオテクノロジー企業、製薬会社、学術＆研究機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他）分析、競争分析、調査プロセスなどを掲載しています。なお、本書の主要企業として、Thermo Fisher Scientific Inc.、Merck KgaA、F. Hoffmann-La Roche AG、Becton, Dickinson and Company、STEMCELL Technologies Inc.、Miltenyi Biotec、GE Healthcare 、Sartorius AG、Lonza Group AG、Danaher Corporation などが含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の細胞解離市場規模：種類別
- 組織解離の市場規模
- 細胞剥離の市場規模
・世界の細胞解離市場規模：製品種類別
- 酵素的解離製品の市場規模
- 非酵素的解離製品の市場規模
- 器具＆付属品の市場規模
・世界の細胞解離市場規模：組織別
- 上皮組織の市場規模
- 結合組織の市場規模
- その他組織の市場規模
・世界の細胞解離市場規模：エンドユーザー別
- バイオテクノロジー企業における市場規模
- 製薬会社における市場規模
- 学術＆研究機関における市場規模
- その他エンドユーザーにおける市場規模
・世界の細胞解離市場規模：地域別
- 北米の細胞解離市場規模
- ヨーロッパの細胞解離市場規模
- アジア太平洋の細胞解離市場規模
- 中南米の細胞解離市場規模
- その他地域の細胞解離市場規模
・競争分析
・調査プロセス |
Global Cell Dissociation Market is valued at approximately USD 282 million in 2021 and is anticipated to grow with a healthy growth rate of more than 14.7% over the forecast period 2022-2029. Cell dissociation is a procedure used in the laboratory to separate cells from tissue or other cells. A proteolytic enzyme is employed in this procedure, also referred as trypsinization, to break down proteins and remove cells from cell culture media. Cell dissociation is required for a multitude of scientific and therapeutic applications such as drug discovery and development, cell therapy and tissue engineering, need cell separation. Growing government funding for cell-based research, an increase in biopharmaceutical firms’ R&D efforts, and a growing emphasis on personalized treatment, where cell dissociation plays a key part, are some of the drivers driving the market’s expansion.
In addition, the growing concern for health among mass and the emergence of various diseases are being tackled by the contribution of governments to institutes for development. The American Administration for Health has nearly provided USD 3.7 Billion for research on all forms of cells and in the sector of life sciences. Also, the Government of India’s Department of Biotechnology has granted over USD 600 Thousand for cell-based research to institutes for Cellular and Molecular Biology and National Research. These contributions are leading to advancements in the technology for research and development which is likely to attract demand globally for cell dissociation products. Furthermore, the significant rise in investments in emerging economies for cell-based research is providing growth opportunities for players operating in the cell dissociation market. Also, there is a rise in R&D projects and the development of technologies for cell-based research. However, high costs are associated with cell dissociation and cell-based research which is restricting the market growth over the forecast period of 2022-2029.
The key regions considered for the Global Cell Dissociation Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America in accounted for the largest share of the cell dissociation market, contributing to the increase in research in pharmaceutical and biotechnological industries. Whereas, Europe is also expected to grow at the highest growth rate over the forecasting period. Factors such as rising drug discovery, rising research and development activities for the development of tissue engineering and rising therapeutic applications are burgeoning the market growth in the forecasting years.
Major market players included in this report are:
Thermo Fisher Scientific Inc.
Merck KgaA
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
STEMCELL Technologies Inc.
Miltenyi Biotec
GE Healthcare
Sartorius AG
Lonza Group AG
Danaher Corporation
Recent Developments in the Market:
In February 2023, Thermo Fisher Scientific and Celltrio, a leading producer of robotics-based technology for the life sciences industry, announced an alliance to provide biotherapeutics customers with a completely automated cell culture system.
In March 2021, Roche Diagnostics and Gen Mark Diagnostics signed a legally binding merger agreement in order to have access to cutting-edge technologies for testing a variety of diseases in a single patient sample.
Global Cell Dissociation Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Product Type, Tissue, End User,
Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Tissue Dissociation
Cell Detachment
By Product Type:
Enzymatic Dissociation Products
Non-Enzymatic Dissociation Products
Instruments & Accessories
By Tissue:
Epithelial Tissue
Connective Tissue
Others
By End User:
Biotechnology Companies
Pharmaceutical Companies
Academic and Research Institutes
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Cell dissociation market, by Region, 2019-2029 (USD Million)
1.2.2. Cell dissociation market, by Type, 2019-2029 (USD Million)
1.2.3. Cell dissociation market, by Product Type, 2019-2029 (USD Million)
1.2.4. Cell dissociation market, by Tissue, 2019-2029 (USD Million)
1.2.5. Cell dissociation market, by End User, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell dissociation market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell dissociation market Dynamics
3.1. Cell dissociation market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing Government support for Cell-Based Research
3.1.1.2. Growth in research and development initiatives by biopharmaceutical companies
3.1.1.3. Increased focus on personalized medicine where cell dissociation plays a vital role
3.1.2. Market Challenges
3.1.2.1. High costs associated with cell-based research activities
3.1.3. Market Opportunities
3.1.3.1. Significant rise in investments in Emerging economies for cell-based research players
3.1.3.2. Rise in R&D projects in the field of life sciences and Development of technologies for cell-based research
Chapter 4. Global Cell dissociation market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cell dissociation market, by Type
6.1. Market Snapshot
6.2. Global Cell dissociation market by Type, Performance – Potential Analysis
6.3. Global Cell dissociation market Estimates & Forecasts by Type 2019-2029 (USD Million)
6.4. Cell dissociation market, Sub Segment Analysis
6.4.1. Tissue Dissociation
6.4.2. Cell Detachment
Chapter 7. Global Cell dissociation market, by Product Type
7.1. Market Snapshot
7.2. Global Cell dissociation market by Product Type, Performance – Potential Analysis
7.3. Global Cell dissociation market Estimates & Forecasts by Product Type 2019-2029 (USD Million)
7.4. Cell dissociation market, Sub Segment Analysis
7.4.1. Enzymatic Dissociation Products
7.4.2. Non-Enzymatic Dissociation Products
7.4.3. Instruments & Accessories
Chapter 8. Global Cell dissociation market, by Tissue
8.1. Market Snapshot
8.2. Global Cell dissociation market by Tissue, Performance – Potential Analysis
8.3. Global Cell dissociation market Estimates & Forecasts by Tissue 2019-2029 (USD Million)
8.4. Cell dissociation market, Sub Segment Analysis
8.4.1. Epithelial Tissue
8.4.2. Connective Tissue
8.4.3. Others
Chapter 9. Global Cell dissociation market, by End User
9.1. Market Snapshot
9.2. Global Cell dissociation market by End User, Performance – Potential Analysis
9.3. Global Cell dissociation market Estimates & Forecasts by End User 2019-2029 (USD Million)
9.4. Cell dissociation market, Sub Segment Analysis
9.4.1. Biotechnology Companies
9.4.2. Pharmaceutical Companies
9.4.3. Academic and Research Institutes
9.4.4. Others
Chapter 10. Global Cell dissociation market, Regional Analysis
10.1. Cell dissociation market, Regional Market Snapshot
10.2. North America Cell dissociation market
10.2.1. U.S. Cell dissociation market
10.2.1.1. Type breakdown estimates & forecasts, 2019-2029
10.2.1.2. Product Type breakdown estimates & forecasts, 2019-2029
10.2.1.3. By Tissue breakdown estimates & forecasts, 2019-2029
10.2.1.4. End User breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Cell dissociation market
10.3. Europe Cell dissociation market Snapshot
10.3.1. U.K. Cell dissociation market
10.3.2. Germany Cell dissociation market
10.3.3. France Cell dissociation market
10.3.4. Spain Cell dissociation market
10.3.5. Italy Cell dissociation market
10.3.6. Rest of Europe Cell dissociation market
10.4. Asia-Pacific Cell dissociation market Snapshot
10.4.1. China Cell dissociation market
10.4.2. India Cell dissociation market
10.4.3. Japan Cell dissociation market
10.4.4. Australia Cell dissociation market
10.4.5. South Korea Cell dissociation market
10.4.6. Rest of Asia Pacific Cell dissociation market
10.5. Latin America Cell dissociation market Snapshot
10.5.1. Brazil Cell dissociation market
10.5.2. Mexico Cell dissociation market
10.5.3. Rest of Latin America Cell dissociation market
10.6. Rest of The World Cell dissociation market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Merck KgaA
11.2.3. F. Hoffmann-La Roche AG
11.2.4. Becton, Dickinson and Company
11.2.5. STEMCELL Technologies Inc.
11.2.6. Miltenyi Biotec
11.2.7. GE Healthcare
11.2.8. Sartorius AG
11.2.9. Lonza Group AG
11.2.10. Danaher Corporation
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
